Celldex Therapeutics | CLDX - Ebitda





Ebitda Veränderung Datum
AbbVie USD 3.69B 1.68B 2026-03
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 3.86B 1.28B 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Celldex Therapeutics USD -83.58M 2.76M 2026-03
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Pfizer USD 6.01B 18M 2026-06
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Roche Holding CHF 13.43B 744M 2026-06